Could the anti-modified protein antibody concept help better define seronegative rheumatoid arthritis?

The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs

Comparative analysis of clinical profile, therapeutic management, and clinical prognosis of patients with seropositive or seronegative rheumatoid arthritis following the introduction of a first targeted therapy in a real-life setting

Joint involvement in VEXAS and non-VEXAS clonal haematopoiesis: two clusters from a multicentre regional cohort

Evaluation by modern imaging of anterior chest wall involvement in axial spondyloarthritis with or without chest complaint

Potential efficacy of T and B lymphocyte-targeted therapies on articular involvement of patients with rheumatoid arthritis and systemic sclerosis overlap syndrome. Results from a 2-centre series of 19 cases

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

Lupus With Erosive Arthritis: A Singular Joint Phenotype of Lupus or Rhupus?

Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts

Immune reactivity directed against the carbamylated fibrinogen α chain does not cross-react with citrullinated fibrinogen immunodominant peptides in patients with rheumatoid arthritis

On difficulties to define prognostic factors for clinical practice in rheumatoid arthritis

2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis

Determinants associated with the prescription of a first biologic therapy in patients with axial spondyloarthritis and concomitant fibromyalgia in daily practice

Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity

Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort

Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study

Association Between the Number of Comorbidities and the Risk of a Serious Infection in Rheumatoid Arthritis Treated by a First Biologic Agent

A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

The impact of an in-department pharmacist on the prevention of drug iatrogenesis in a rheumatology department

Rheumatologic manifestations of sarcoidosis and increased risk of spondyloarthritis occurrence. A retrospective single center case-control study

Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing In Vivo Epitopes of Its γ Chain One of Which Is Not Cross Reactive With Anti-Citrullinated Protein Antibodies

Clinical impact of a personalized pharmaceutical plan on opioid management in non-cancer pain: a pilot study

Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort

Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study

Valvular and infection-associated risk factors as criteria to guide the use of echocardiography in patients with native joint infections

Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients

Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis

Castleman's disease in two patients with spondyloarthritis treated by Tumor Necrosis Factor-alpha antagonists

A case of Whipple's disease mimicking auto-inflammatory disease and revealed by severe right cardiac failure under anakinra

Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data

Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts

Characterisation of airway disease associated with Sjögren disease

Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study

Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)

Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS

Autoantibody fine specificity restriction is associated with clinical response in RA treated with abatacept and methotrexate

Macrophage requirements for abatacept response in rheumatoid arthritis

Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry

Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study

Potential Benefit of Rituximab in Rhupus Patients From a Single-Center: A Series of 16 Cases

Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis

Autoantibody fine specificity restriction is associated with clinical response in RA treated with abatacept and methotrexate

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination

Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis

Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism

Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination

Association between treatment type and therapeutic response according to clinical form of SAPHO syndrome in adults from a multicentre retrospective cohort study

Microbiological diagnosis of suspected vertebral osteomyelitis with a focus on the yield of percutaneous needle biopsy: a 10-year cohort study

Impact of the Clinical Pharmacist in Rheumatology Practice: A Systematic Review

Impact of the Clinical Pharmacist in Rheumatology Practice: A Systematic Review

Does iron deficiency contribute to fatigue in patients with rheumatoid arthritis without anemia?

A pilot study of refractory enthesitis treated with CO(2) laser in spondyloarthritis and psoriatic arthritis